Investors, Inovio Get Final OK For $44M Deal In Stock Suit
By P.J. D'Annunzio · January 18, 2023, 5:10 PM EST
A Pennsylvania federal judge on Wednesday approved a $44 million deal between biotechnology firm Inovio Pharmaceuticals Inc. and its investors to resolve claims that the company's alleged misrepresentation of its COVID-19...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login